MOLECULAR THERAPY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566532, encodeId=8733566532cf, content=我12月初投稿号是3403，四个月才增加500多的投稿数，不知道这个稿号排到3400是怎么排的？从来没有遇到过投稿两个月还没有分配编辑的，现在都不知道怎么办拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, beContent=拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574079, encodeId=8c4b5e40799d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：ASGCT的主刊，年稿量范围在160-210左右，流程仅供参考 Stage Start Date Post Decision 08-Jun-2019 11:08:56 Decision Made 08-Jun-2019 11:08:38 Editorial review 30-May-2019 06:29:26 Submission 30-May-2019 05:58:02 Stage Start Date Revision Received 30-May-2019 05:58:02 Waiting for Revision 28-May-2019 10:24:33 Decision Made 28-May-2019 10:24:32 Decision Pending 27-May-2019 23:02:01 Monitoring editor review started 27-May-2019 10:04:35 25-May-2019 08:11:19 All reviews received 25-May-2019 08:11:19 Under review 14-May-2019 15:52:47 Contacting reviewers 13-May-2019 21:33:18 Editorial review 13-May-2019 06:09:58 Submission 13-May-2019 04:45:59 Stage Start Date Revision Received 13-May-2019 04:45:59 Waiting for Revision 25-Mar-2019 10:57:27 Decision Made 25-Mar-2019 10:57:27 Decision Pending 25-Mar-2019 10:33:42 Monitoring editor review started 25-Mar-2019 10:04:33 23-Mar-2019 01:00:36 All reviews received 23-Mar-2019 01:00:36 Under review 21-Feb-2019 01:37:10 Contacting reviewers 19-Feb-2019 03:06:34 Editorial review 06-Feb-2019 14:39:25 Under Consideration 03-Feb-2019 09:17:32 Submission 22-Jan-2019 11:25:44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Fri Jul 26 00:00:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？188****6831暂无昵称 2020-01-05 00:00:00 发表: 请问需要原始数据吗？, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。Dr H 2019-02-06 00:00:00 发表: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, beContent=Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：非常好的杂志，之前为nature出版社，现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志，势头强进。审稿较快，一般一个月以内，快的2周，审稿人都是本领域大牛，问题一针见血，修稿时间有时不给期限限制，有的多达10个月反复修改。收取版面费，超过8页加钱，彩图收费，且投稿时要明确说明哪些是彩图。课题创新性要强，实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展？一审时间多久啊？princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=)]

2021-12-28 MS54455111222

文章类型和选刊有关系吗？

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566532, encodeId=8733566532cf, content=我12月初投稿号是3403，四个月才增加500多的投稿数，不知道这个稿号排到3400是怎么排的？从来没有遇到过投稿两个月还没有分配编辑的，现在都不知道怎么办拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, beContent=拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574079, encodeId=8c4b5e40799d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：ASGCT的主刊，年稿量范围在160-210左右，流程仅供参考 Stage Start Date Post Decision 08-Jun-2019 11:08:56 Decision Made 08-Jun-2019 11:08:38 Editorial review 30-May-2019 06:29:26 Submission 30-May-2019 05:58:02 Stage Start Date Revision Received 30-May-2019 05:58:02 Waiting for Revision 28-May-2019 10:24:33 Decision Made 28-May-2019 10:24:32 Decision Pending 27-May-2019 23:02:01 Monitoring editor review started 27-May-2019 10:04:35 25-May-2019 08:11:19 All reviews received 25-May-2019 08:11:19 Under review 14-May-2019 15:52:47 Contacting reviewers 13-May-2019 21:33:18 Editorial review 13-May-2019 06:09:58 Submission 13-May-2019 04:45:59 Stage Start Date Revision Received 13-May-2019 04:45:59 Waiting for Revision 25-Mar-2019 10:57:27 Decision Made 25-Mar-2019 10:57:27 Decision Pending 25-Mar-2019 10:33:42 Monitoring editor review started 25-Mar-2019 10:04:33 23-Mar-2019 01:00:36 All reviews received 23-Mar-2019 01:00:36 Under review 21-Feb-2019 01:37:10 Contacting reviewers 19-Feb-2019 03:06:34 Editorial review 06-Feb-2019 14:39:25 Under Consideration 03-Feb-2019 09:17:32 Submission 22-Jan-2019 11:25:44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Fri Jul 26 00:00:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？188****6831暂无昵称 2020-01-05 00:00:00 发表: 请问需要原始数据吗？, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。Dr H 2019-02-06 00:00:00 发表: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, beContent=Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：非常好的杂志，之前为nature出版社，现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志，势头强进。审稿较快，一般一个月以内，快的2周，审稿人都是本领域大牛，问题一针见血，修稿时间有时不给期限限制，有的多达10个月反复修改。收取版面费，超过8页加钱，彩图收费，且投稿时要明确说明哪些是彩图。课题创新性要强，实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展？一审时间多久啊？princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=)]

2021-08-18 二手科学家

这个杂志最近貌似快成lncRNA专刊了

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566532, encodeId=8733566532cf, content=我12月初投稿号是3403，四个月才增加500多的投稿数，不知道这个稿号排到3400是怎么排的？从来没有遇到过投稿两个月还没有分配编辑的，现在都不知道怎么办拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, beContent=拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574079, encodeId=8c4b5e40799d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：ASGCT的主刊，年稿量范围在160-210左右，流程仅供参考 Stage Start Date Post Decision 08-Jun-2019 11:08:56 Decision Made 08-Jun-2019 11:08:38 Editorial review 30-May-2019 06:29:26 Submission 30-May-2019 05:58:02 Stage Start Date Revision Received 30-May-2019 05:58:02 Waiting for Revision 28-May-2019 10:24:33 Decision Made 28-May-2019 10:24:32 Decision Pending 27-May-2019 23:02:01 Monitoring editor review started 27-May-2019 10:04:35 25-May-2019 08:11:19 All reviews received 25-May-2019 08:11:19 Under review 14-May-2019 15:52:47 Contacting reviewers 13-May-2019 21:33:18 Editorial review 13-May-2019 06:09:58 Submission 13-May-2019 04:45:59 Stage Start Date Revision Received 13-May-2019 04:45:59 Waiting for Revision 25-Mar-2019 10:57:27 Decision Made 25-Mar-2019 10:57:27 Decision Pending 25-Mar-2019 10:33:42 Monitoring editor review started 25-Mar-2019 10:04:33 23-Mar-2019 01:00:36 All reviews received 23-Mar-2019 01:00:36 Under review 21-Feb-2019 01:37:10 Contacting reviewers 19-Feb-2019 03:06:34 Editorial review 06-Feb-2019 14:39:25 Under Consideration 03-Feb-2019 09:17:32 Submission 22-Jan-2019 11:25:44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Fri Jul 26 00:00:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？188****6831暂无昵称 2020-01-05 00:00:00 发表: 请问需要原始数据吗？, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。Dr H 2019-02-06 00:00:00 发表: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, beContent=Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：非常好的杂志，之前为nature出版社，现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志，势头强进。审稿较快，一般一个月以内，快的2周，审稿人都是本领域大牛，问题一针见血，修稿时间有时不给期限限制，有的多达10个月反复修改。收取版面费，超过8页加钱，彩图收费，且投稿时要明确说明哪些是彩图。课题创新性要强，实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展？一审时间多久啊？princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=)]

2019-02-07 krygios

我12月初投稿号是3403，四个月才增加500多的投稿数，不知道这个稿号排到3400是怎么排的？从来没有遇到过投稿两个月还没有分配编辑的，现在都不知道怎么办拼搏必成 2019-02-06 00:00:00 发表:
年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。

拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。

194 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566532, encodeId=8733566532cf, content=我12月初投稿号是3403，四个月才增加500多的投稿数，不知道这个稿号排到3400是怎么排的？从来没有遇到过投稿两个月还没有分配编辑的，现在都不知道怎么办拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, beContent=拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574079, encodeId=8c4b5e40799d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：ASGCT的主刊，年稿量范围在160-210左右，流程仅供参考 Stage Start Date Post Decision 08-Jun-2019 11:08:56 Decision Made 08-Jun-2019 11:08:38 Editorial review 30-May-2019 06:29:26 Submission 30-May-2019 05:58:02 Stage Start Date Revision Received 30-May-2019 05:58:02 Waiting for Revision 28-May-2019 10:24:33 Decision Made 28-May-2019 10:24:32 Decision Pending 27-May-2019 23:02:01 Monitoring editor review started 27-May-2019 10:04:35 25-May-2019 08:11:19 All reviews received 25-May-2019 08:11:19 Under review 14-May-2019 15:52:47 Contacting reviewers 13-May-2019 21:33:18 Editorial review 13-May-2019 06:09:58 Submission 13-May-2019 04:45:59 Stage Start Date Revision Received 13-May-2019 04:45:59 Waiting for Revision 25-Mar-2019 10:57:27 Decision Made 25-Mar-2019 10:57:27 Decision Pending 25-Mar-2019 10:33:42 Monitoring editor review started 25-Mar-2019 10:04:33 23-Mar-2019 01:00:36 All reviews received 23-Mar-2019 01:00:36 Under review 21-Feb-2019 01:37:10 Contacting reviewers 19-Feb-2019 03:06:34 Editorial review 06-Feb-2019 14:39:25 Under Consideration 03-Feb-2019 09:17:32 Submission 22-Jan-2019 11:25:44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Fri Jul 26 00:00:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？188****6831暂无昵称 2020-01-05 00:00:00 发表: 请问需要原始数据吗？, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。Dr H 2019-02-06 00:00:00 发表: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, beContent=Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：非常好的杂志，之前为nature出版社，现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志，势头强进。审稿较快，一般一个月以内，快的2周，审稿人都是本领域大牛，问题一针见血，修稿时间有时不给期限限制，有的多达10个月反复修改。收取版面费，超过8页加钱，彩图收费，且投稿时要明确说明哪些是彩图。课题创新性要强，实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展？一审时间多久啊？princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=)]

2019-07-26 SYHenry

审稿速度:6.0 | 投稿命中率:5.0
经验分享：ASGCT的主刊，年稿量范围在160-210左右，流程仅供参考 Stage Start Date Post Decision 08-Jun-2019 11:08:56 Decision Made 08-Jun-2019 11:08:38 Editorial review 30-May-2019 06:29:26 Submission 30-May-2019 05:58:02 Stage Start Date Revision Received 30-May-2019 05:58:02 Waiting for Revision 28-May-2019 10:24:33 Decision Made 28-May-2019 10:24:32 Decision Pending 27-May-2019 23:02:01 Monitoring editor review started 27-May-2019 10:04:35 25-May-2019 08:11:19 All reviews received 25-May-2019 08:11:19 Under review 14-May-2019 15:52:47 Contacting reviewers 13-May-2019 21:33:18 Editorial review 13-May-2019 06:09:58 Submission 13-May-2019 04:45:59 Stage Start Date Revision Received 13-May-2019 04:45:59 Waiting for Revision 25-Mar-2019 10:57:27 Decision Made 25-Mar-2019 10:57:27 Decision Pending 25-Mar-2019 10:33:42 Monitoring editor review started 25-Mar-2019 10:04:33 23-Mar-2019 01:00:36 All reviews received 23-Mar-2019 01:00:36 Under review 21-Feb-2019 01:37:10 Contacting reviewers 19-Feb-2019 03:06:34 Editorial review 06-Feb-2019 14:39:25 Under Consideration 03-Feb-2019 09:17:32 Submission 22-Jan-2019 11:25:44

207 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566532, encodeId=8733566532cf, content=我12月初投稿号是3403，四个月才增加500多的投稿数，不知道这个稿号排到3400是怎么排的？从来没有遇到过投稿两个月还没有分配编辑的，现在都不知道怎么办拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, beContent=拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574079, encodeId=8c4b5e40799d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：ASGCT的主刊，年稿量范围在160-210左右，流程仅供参考 Stage Start Date Post Decision 08-Jun-2019 11:08:56 Decision Made 08-Jun-2019 11:08:38 Editorial review 30-May-2019 06:29:26 Submission 30-May-2019 05:58:02 Stage Start Date Revision Received 30-May-2019 05:58:02 Waiting for Revision 28-May-2019 10:24:33 Decision Made 28-May-2019 10:24:32 Decision Pending 27-May-2019 23:02:01 Monitoring editor review started 27-May-2019 10:04:35 25-May-2019 08:11:19 All reviews received 25-May-2019 08:11:19 Under review 14-May-2019 15:52:47 Contacting reviewers 13-May-2019 21:33:18 Editorial review 13-May-2019 06:09:58 Submission 13-May-2019 04:45:59 Stage Start Date Revision Received 13-May-2019 04:45:59 Waiting for Revision 25-Mar-2019 10:57:27 Decision Made 25-Mar-2019 10:57:27 Decision Pending 25-Mar-2019 10:33:42 Monitoring editor review started 25-Mar-2019 10:04:33 23-Mar-2019 01:00:36 All reviews received 23-Mar-2019 01:00:36 Under review 21-Feb-2019 01:37:10 Contacting reviewers 19-Feb-2019 03:06:34 Editorial review 06-Feb-2019 14:39:25 Under Consideration 03-Feb-2019 09:17:32 Submission 22-Jan-2019 11:25:44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Fri Jul 26 00:00:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？188****6831暂无昵称 2020-01-05 00:00:00 发表: 请问需要原始数据吗？, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。Dr H 2019-02-06 00:00:00 发表: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, beContent=Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：非常好的杂志，之前为nature出版社，现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志，势头强进。审稿较快，一般一个月以内，快的2周，审稿人都是本领域大牛，问题一针见血，修稿时间有时不给期限限制，有的多达10个月反复修改。收取版面费，超过8页加钱，彩图收费，且投稿时要明确说明哪些是彩图。课题创新性要强，实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展？一审时间多久啊？princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=)]

2019-03-19 princesun083

审稿速度:24.0 | 投稿命中率:25.0
经验分享：历经审稿一年多，终于收了，这个杂志不要审稿太仔细！

183 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566532, encodeId=8733566532cf, content=我12月初投稿号是3403，四个月才增加500多的投稿数，不知道这个稿号排到3400是怎么排的？从来没有遇到过投稿两个月还没有分配编辑的，现在都不知道怎么办拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, beContent=拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574079, encodeId=8c4b5e40799d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：ASGCT的主刊，年稿量范围在160-210左右，流程仅供参考 Stage Start Date Post Decision 08-Jun-2019 11:08:56 Decision Made 08-Jun-2019 11:08:38 Editorial review 30-May-2019 06:29:26 Submission 30-May-2019 05:58:02 Stage Start Date Revision Received 30-May-2019 05:58:02 Waiting for Revision 28-May-2019 10:24:33 Decision Made 28-May-2019 10:24:32 Decision Pending 27-May-2019 23:02:01 Monitoring editor review started 27-May-2019 10:04:35 25-May-2019 08:11:19 All reviews received 25-May-2019 08:11:19 Under review 14-May-2019 15:52:47 Contacting reviewers 13-May-2019 21:33:18 Editorial review 13-May-2019 06:09:58 Submission 13-May-2019 04:45:59 Stage Start Date Revision Received 13-May-2019 04:45:59 Waiting for Revision 25-Mar-2019 10:57:27 Decision Made 25-Mar-2019 10:57:27 Decision Pending 25-Mar-2019 10:33:42 Monitoring editor review started 25-Mar-2019 10:04:33 23-Mar-2019 01:00:36 All reviews received 23-Mar-2019 01:00:36 Under review 21-Feb-2019 01:37:10 Contacting reviewers 19-Feb-2019 03:06:34 Editorial review 06-Feb-2019 14:39:25 Under Consideration 03-Feb-2019 09:17:32 Submission 22-Jan-2019 11:25:44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Fri Jul 26 00:00:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？188****6831暂无昵称 2020-01-05 00:00:00 发表: 请问需要原始数据吗？, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。Dr H 2019-02-06 00:00:00 发表: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, beContent=Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：非常好的杂志，之前为nature出版社，现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志，势头强进。审稿较快，一般一个月以内，快的2周，审稿人都是本领域大牛，问题一针见血，修稿时间有时不给期限限制，有的多达10个月反复修改。收取版面费，超过8页加钱，彩图收费，且投稿时要明确说明哪些是彩图。课题创新性要强，实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展？一审时间多久啊？princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=)]

2020-01-19 145fac5am20暂无昵称

需要188****6831暂无昵称 2020-01-05 发表::
请问需要原始数据吗？188****6831暂无昵称 2020-01-05 00:00:00 发表:
请问需要原始数据吗？

188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？

139 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566532, encodeId=8733566532cf, content=我12月初投稿号是3403，四个月才增加500多的投稿数，不知道这个稿号排到3400是怎么排的？从来没有遇到过投稿两个月还没有分配编辑的，现在都不知道怎么办拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, beContent=拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574079, encodeId=8c4b5e40799d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：ASGCT的主刊，年稿量范围在160-210左右，流程仅供参考 Stage Start Date Post Decision 08-Jun-2019 11:08:56 Decision Made 08-Jun-2019 11:08:38 Editorial review 30-May-2019 06:29:26 Submission 30-May-2019 05:58:02 Stage Start Date Revision Received 30-May-2019 05:58:02 Waiting for Revision 28-May-2019 10:24:33 Decision Made 28-May-2019 10:24:32 Decision Pending 27-May-2019 23:02:01 Monitoring editor review started 27-May-2019 10:04:35 25-May-2019 08:11:19 All reviews received 25-May-2019 08:11:19 Under review 14-May-2019 15:52:47 Contacting reviewers 13-May-2019 21:33:18 Editorial review 13-May-2019 06:09:58 Submission 13-May-2019 04:45:59 Stage Start Date Revision Received 13-May-2019 04:45:59 Waiting for Revision 25-Mar-2019 10:57:27 Decision Made 25-Mar-2019 10:57:27 Decision Pending 25-Mar-2019 10:33:42 Monitoring editor review started 25-Mar-2019 10:04:33 23-Mar-2019 01:00:36 All reviews received 23-Mar-2019 01:00:36 Under review 21-Feb-2019 01:37:10 Contacting reviewers 19-Feb-2019 03:06:34 Editorial review 06-Feb-2019 14:39:25 Under Consideration 03-Feb-2019 09:17:32 Submission 22-Jan-2019 11:25:44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Fri Jul 26 00:00:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？188****6831暂无昵称 2020-01-05 00:00:00 发表: 请问需要原始数据吗？, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。Dr H 2019-02-06 00:00:00 发表: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, beContent=Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：非常好的杂志，之前为nature出版社，现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志，势头强进。审稿较快，一般一个月以内，快的2周，审稿人都是本领域大牛，问题一针见血，修稿时间有时不给期限限制，有的多达10个月反复修改。收取版面费，超过8页加钱，彩图收费，且投稿时要明确说明哪些是彩图。课题创新性要强，实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展？一审时间多久啊？princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=)]

2019-02-06 拼搏必成

年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表::
完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。Dr H 2019-02-06 00:00:00 发表:
完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。

Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。

209 0

[GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566532, encodeId=8733566532cf, content=我12月初投稿号是3403，四个月才增加500多的投稿数，不知道这个稿号排到3400是怎么排的？从来没有遇到过投稿两个月还没有分配编辑的，现在都不知道怎么办拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, beContent=拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574079, encodeId=8c4b5e40799d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：ASGCT的主刊，年稿量范围在160-210左右，流程仅供参考 Stage Start Date Post Decision 08-Jun-2019 11:08:56 Decision Made 08-Jun-2019 11:08:38 Editorial review 30-May-2019 06:29:26 Submission 30-May-2019 05:58:02 Stage Start Date Revision Received 30-May-2019 05:58:02 Waiting for Revision 28-May-2019 10:24:33 Decision Made 28-May-2019 10:24:32 Decision Pending 27-May-2019 23:02:01 Monitoring editor review started 27-May-2019 10:04:35 25-May-2019 08:11:19 All reviews received 25-May-2019 08:11:19 Under review 14-May-2019 15:52:47 Contacting reviewers 13-May-2019 21:33:18 Editorial review 13-May-2019 06:09:58 Submission 13-May-2019 04:45:59 Stage Start Date Revision Received 13-May-2019 04:45:59 Waiting for Revision 25-Mar-2019 10:57:27 Decision Made 25-Mar-2019 10:57:27 Decision Pending 25-Mar-2019 10:33:42 Monitoring editor review started 25-Mar-2019 10:04:33 23-Mar-2019 01:00:36 All reviews received 23-Mar-2019 01:00:36 Under review 21-Feb-2019 01:37:10 Contacting reviewers 19-Feb-2019 03:06:34 Editorial review 06-Feb-2019 14:39:25 Under Consideration 03-Feb-2019 09:17:32 Submission 22-Jan-2019 11:25:44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Fri Jul 26 00:00:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？188****6831暂无昵称 2020-01-05 00:00:00 发表: 请问需要原始数据吗？, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。Dr H 2019-02-06 00:00:00 发表: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, beContent=Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：非常好的杂志，之前为nature出版社，现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志，势头强进。审稿较快，一般一个月以内，快的2周，审稿人都是本领域大牛，问题一针见血，修稿时间有时不给期限限制，有的多达10个月反复修改。收取版面费，超过8页加钱，彩图收费，且投稿时要明确说明哪些是彩图。课题创新性要强，实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展？一审时间多久啊？princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=)]

2019-03-28 fame198288

审稿速度:3.0 | 投稿命中率:25.0
经验分享：非常好的杂志，之前为nature出版社，现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志，势头强进。审稿较快，一般一个月以内，快的2周，审稿人都是本领域大牛，问题一针见血，修稿时间有时不给期限限制，有的多达10个月反复修改。收取版面费，超过8页加钱，彩图收费，且投稿时要明确说明哪些是彩图。课题创新性要强，实验设计的完整性要充分。

208 0

[GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566532, encodeId=8733566532cf, content=我12月初投稿号是3403，四个月才增加500多的投稿数，不知道这个稿号排到3400是怎么排的？从来没有遇到过投稿两个月还没有分配编辑的，现在都不知道怎么办拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, beContent=拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574079, encodeId=8c4b5e40799d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：ASGCT的主刊，年稿量范围在160-210左右，流程仅供参考 Stage Start Date Post Decision 08-Jun-2019 11:08:56 Decision Made 08-Jun-2019 11:08:38 Editorial review 30-May-2019 06:29:26 Submission 30-May-2019 05:58:02 Stage Start Date Revision Received 30-May-2019 05:58:02 Waiting for Revision 28-May-2019 10:24:33 Decision Made 28-May-2019 10:24:32 Decision Pending 27-May-2019 23:02:01 Monitoring editor review started 27-May-2019 10:04:35 25-May-2019 08:11:19 All reviews received 25-May-2019 08:11:19 Under review 14-May-2019 15:52:47 Contacting reviewers 13-May-2019 21:33:18 Editorial review 13-May-2019 06:09:58 Submission 13-May-2019 04:45:59 Stage Start Date Revision Received 13-May-2019 04:45:59 Waiting for Revision 25-Mar-2019 10:57:27 Decision Made 25-Mar-2019 10:57:27 Decision Pending 25-Mar-2019 10:33:42 Monitoring editor review started 25-Mar-2019 10:04:33 23-Mar-2019 01:00:36 All reviews received 23-Mar-2019 01:00:36 Under review 21-Feb-2019 01:37:10 Contacting reviewers 19-Feb-2019 03:06:34 Editorial review 06-Feb-2019 14:39:25 Under Consideration 03-Feb-2019 09:17:32 Submission 22-Jan-2019 11:25:44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Fri Jul 26 00:00:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？188****6831暂无昵称 2020-01-05 00:00:00 发表: 请问需要原始数据吗？, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。Dr H 2019-02-06 00:00:00 发表: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, beContent=Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：非常好的杂志，之前为nature出版社，现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志，势头强进。审稿较快，一般一个月以内，快的2周，审稿人都是本领域大牛，问题一针见血，修稿时间有时不给期限限制，有的多达10个月反复修改。收取版面费，超过8页加钱，彩图收费，且投稿时要明确说明哪些是彩图。课题创新性要强，实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展？一审时间多久啊？princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=)]

2019-03-20 nanana

能否分享一下整个过程进展？一审时间多久啊？princesun083 2019-03-19 00:00:00 发表:
历经审稿一年多，终于收了，这个杂志不要审稿太仔细！

princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！

195 0

[GetPortalCommentsPageByObjectIdResponse(id=1095566, encodeId=cf9e10955667d, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008918, encodeId=9768100891841, content=这个杂志最近貌似快成lncRNA专刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43295231161, createdName=二手科学家, createdTime=Wed Aug 18 08:55:51 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566532, encodeId=8733566532cf, content=我12月初投稿号是3403，四个月才增加500多的投稿数，不知道这个稿号排到3400是怎么排的？从来没有遇到过投稿两个月还没有分配编辑的，现在都不知道怎么办拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, beContent=拼搏必成 2019-02-06 00:00:00 发表: 年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Feb 07 00:00:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574079, encodeId=8c4b5e40799d, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：ASGCT的主刊，年稿量范围在160-210左右，流程仅供参考 Stage Start Date Post Decision 08-Jun-2019 11:08:56 Decision Made 08-Jun-2019 11:08:38 Editorial review 30-May-2019 06:29:26 Submission 30-May-2019 05:58:02 Stage Start Date Revision Received 30-May-2019 05:58:02 Waiting for Revision 28-May-2019 10:24:33 Decision Made 28-May-2019 10:24:32 Decision Pending 27-May-2019 23:02:01 Monitoring editor review started 27-May-2019 10:04:35 25-May-2019 08:11:19 All reviews received 25-May-2019 08:11:19 Under review 14-May-2019 15:52:47 Contacting reviewers 13-May-2019 21:33:18 Editorial review 13-May-2019 06:09:58 Submission 13-May-2019 04:45:59 Stage Start Date Revision Received 13-May-2019 04:45:59 Waiting for Revision 25-Mar-2019 10:57:27 Decision Made 25-Mar-2019 10:57:27 Decision Pending 25-Mar-2019 10:33:42 Monitoring editor review started 25-Mar-2019 10:04:33 23-Mar-2019 01:00:36 All reviews received 23-Mar-2019 01:00:36 Under review 21-Feb-2019 01:37:10 Contacting reviewers 19-Feb-2019 03:06:34 Editorial review 06-Feb-2019 14:39:25 Under Consideration 03-Feb-2019 09:17:32 Submission 22-Jan-2019 11:25:44, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Fri Jul 26 00:00:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568297, encodeId=0f2f56829e59, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583596, encodeId=03c858359657, content=需要188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？188****6831暂无昵称 2020-01-05 00:00:00 发表: 请问需要原始数据吗？, beContent=188****6831暂无昵称 2020-01-05 发表:: 请问需要原始数据吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54c25102995, createdName=145fac5am20暂无昵称, createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566505, encodeId=1348566505aa, content=年文章最多216篇，接收率应该是《10%的。我8月初投稿稿件号已经2880了。Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。Dr H 2019-02-06 00:00:00 发表: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, beContent=Dr H 2019-02-06 发表:: 完全同意，虽然这个软件很不错，但是这个软件错误信息太多了，官方完全没有核实过。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/22/a0c4041289d7920f6008c95183c7aa82.jpg, createdBy=bcce1690297, createdName=拼搏必成, createdTime=Wed Feb 06 00:00:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568765, encodeId=5d60568e65d7, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：非常好的杂志，之前为nature出版社，现在归cell press出版。属于美国基因细胞治疗学会的正刊。其家族还包括其他系列杂志，势头强进。审稿较快，一般一个月以内，快的2周，审稿人都是本领域大牛，问题一针见血，修稿时间有时不给期限限制，有的多达10个月反复修改。收取版面费，超过8页加钱，彩图收费，且投稿时要明确说明哪些是彩图。课题创新性要强，实验设计的完整性要充分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9e91459784, createdName=fame198288, createdTime=Thu Mar 28 21:15:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568341, encodeId=598e5683412e, content=能否分享一下整个过程进展？一审时间多久啊？princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, beContent=princesun083 2019-03-19 00:00:00 发表: 历经审稿一年多，终于收了，这个杂志不要审稿太仔细！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/aa5f027eef24954fd6ccd032076f9966.jpg, createdBy=928193395, createdName=nanana, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602387, encodeId=6f7160238eef, content=好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/02/efd7344eb2f4c381b10c1a9b2acaf549.jpg, createdBy=22da73016, createdName=哈哈这就是学术圈, createdTime=Wed Jun 17 07:55:14 CST 2020, time=2020-06-17, status=1, ipAttribution=)]

2020-06-17 哈哈这就是学术圈

好杂志

109 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务